Pfizer, Apotex To End Fight Over Generic Relpax

Law360, Los Angeles (July 27, 2011, 4:19 PM EDT) -- Pfizer Inc. notified a New York federal judge Tuesday that it was close to settling a patent infringement suit over rival Apotex Inc.’s plan to sell a generic version of the migraine drug Relpax.

“We write on behalf of all the parties to apprise the court that all parties are in agreement to settle the action,” Pfizer attorney Michael Kahn of Ropes & Gray LLP said in a letter asking U.S. District Judge Lewis A. Kaplan to extend discovery deadlines in the case. “The parties have...
To view the full article, register now.